Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesLarge age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands
Annals of Oncology, 11/04/09
van Steenbergen LN et al. – The purpose was to assess factors associated with the administration of chemotherapy and their relation to survival at a population–based level. Adherence to guidelines for adjuvant chemotherapy was still suboptimal in 2007, especially for elderly patients, and differed widely between hospitals.
Related Articles
trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II
Cancer Causes and Control, 10/28/09
Relevance Score: 88%
Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study
Journal of Clinical Oncology, 10/02/09
Relevance Score: 88%
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
Gut, 11/09/09
Relevance Score: 87%
Improving colon cancer screening rates in primary care: a pilot study emphasising the role of the medical assistant
Quality & Safety in Health Care, 11/02/09
Relevance Score: 87%
Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer
Journal of Cancer Research & Clinical Oncology, 10/01/09
Relevance Score: 87%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer
Irish Journal of Medical Science, 12/18/09
Application of a stress and coping model to positive and negative adjustment outcomes in colorectal cancer caregiving
Psycho-Oncology, 12/18/09
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women
International Journal of Cancer, 12/18/09
A case-control study of colorectal cancer detection by quantification of DNA isolated from directly collected exfoliated colonocytes
International Journal of Cancer, 12/18/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor